Showing 1 - 8 results of 8 for search 'Dimitrios Christoulas', query time: 0.04s Refine Results
  1. 1
    Pulmonary hypertension in patients with sickle cell/β thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations

    Pulmonary hypertension in patients with sickle cell/β thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations by Ersi Voskaridou, George Tsetsos, Antonios Tsoutsias, Evgenia Spyropoulou, Dimitrios Christoulas, Evangelos Terpos

    Published 2007-06-01
    Get full text
    Article
  2. 2
    Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial

    Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized... by Ersi Voskaridou, Dimitrios Christoulas, Marialena Konstantinidou, Evangelos Tsiftsakis, Panagiotis Alexakos, Evangelos Terpos

    Published 2008-10-01
    Get full text
    Article
  3. 3
    Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration

    Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration by Ersi Voskaridou, Dimitrios Christoulas, Charoula Xirakia, Konstantinos Varvagiannis, Georgios Boutsikas, Antonios Bilalis, Efstathios Kastritis, Athanasios Papatheodorou, Evangelos Terpos

    Published 2009-05-01
    Get full text
    Article
  4. 4
    Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome

    Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome by Evangelos Terpos, Bouchra Asli, Dimitrios Christoulas, Jean-Claude Brouet, Efstathios Kastritis, Michel Rybojad, Djaouida Bengoufa, Meletios A. Dimopoulos, Jean Paul Fermand

    Published 2012-11-01
    Get full text
    Article
  5. 5
    Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

    Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration by Evangelos Terpos, Eirini Katodritou, Evangelos Tsiftsakis, Efstathios Kastritis, Dimitrios Christoulas, Anastasia Pouli, Eurydiki Michalis, Evgenia Verrou, Konstantinos Anargyrou, Konstantinos Tsionos, Meletios A. Dimopoulos, Konstantinos Zervas

    Published 2009-03-01
    Get full text
    Article
  6. 6
    Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

    Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study by Konstantinos Anargyrou, Despina Fotiou, Theodoros P. Vassilakopoulos, Dimitrios Christoulas, Polyzois Makras, Maria Dimou, Ioannis Ntanasis-Stathopoulos, Stavroula Masouridou, Maria K. Angelopoulou, Athanasios Papatheodorou, Konstantinos Tsionos, Panayiotis Panayiotidis, Meletios A. Dimopoulos, Evangelos Terpos

    Published 2019-12-01
    Get full text
    Article
  7. 7
    Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib

    Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib by Konstantinos Anargyrou, Evangelos Terpos, Theodoros P. Vassilakopoulos, Anastasia Pouli, Sotirios Sachanas, Tatiana Tzenou, Stavroula Masouridis, Dimitrios Christoulas, Maria K. Angelopoulou, Evangelia M. Dimitriadou, Christina Kalpadakis, Konstantinos Tsionos, Panayiotis Panayiotidis, Meletios A. Dimopoulos, Gerassimos A. Pangalis, Marie-Christine Kyrtsonis

    Published 2008-03-01
    Get full text
    Article
  8. 8
    The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry

    The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry... by Panagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, Vasiliki Pappa, Argiris Symeonidis, Athanasios Galanopoulos, Panagiotis Zikos, Helen A. Papadaki, Panayiotis Panayiotidis, Maria Dimou, Eleftheria Hatzimichael, George Vassilopoulos, Susan Delimpasis, Despoina Mparmparousi, Sotirios Papageorgiou, Eleni Variami, Marie‐Christine Kyrtsonis, Aekaterini Megalakaki, Maria Kotsopoulou, Panagiotis Repousis, Ioannis Adamopoulos, Flora Kontopidou, Dimitrios Christoulas, Alexandra Kourakli, Dimitrios Tsokanas, Menelaos Konstantinos Papoutselis, Georgios Kyriakakis, Nora‐Athina Viniou, the Hellenic MDS study group

    Published 2019-05-01
    Get full text
    Article

Search Tools: